Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
167.9 USD | +0.32% | +1.84% | -6.90% |
05-21 | Glenmark Pharma Arm to Market Two Beigene Cancer Drugs in India | MT |
05-14 | BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.90% | 17.51B | |
+9.99% | 114B | |
+12.01% | 107B | |
-3.07% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-39.36% | 17.17B | |
+5.82% | 14.14B | |
+33.05% | 12.2B | |
+13.63% | 8.01B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- BeiGene's Brukinsa Secures US FDA Approval for Chronic Lymphocytic Leukemia